[1]
K. Lakshmikanth et al. 2022. FORMULATION, OPTIMIZATION AND EVALUATION OF IMATINIB MESYLATE NANOPARTICLES. Journal of Population Therapeutics and Clinical Pharmacology. 29, 04 (Dec. 2022), 3951–3976. DOI:https://doi.org/10.53555/jptcp.v29i04.6557.